Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

Clinical trial NCT03825289 · TERMINATED

Trial details

NCT number: NCT03825289
Sponsor: University of Utah
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Carcinoma Stage II Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Unresectable Pancreatic Carcinoma

Start date: 2019-01-30
Primary completion: 2025-01-15
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.